Sign in
GSTC Stock Price, Chart, Stats & News
GlobeStar Therapeutics Corporation
Save
GlobeStar Therapeutics Corporation (GSTC) does not currently pay a dividend.
124,111
Market cap
–
Current P/E
–
Forward P/E
GSTC chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
GlobeStar Therapeutics Corporation is a clinical-stage biopharmaceutical firm dedicated to advancing proprietary drug formulations. These innovative treatments specifically target multiple sclerosis (MS) and various other neurodegenerative disorders. Established in 2016, the company was formerly known as AngioSoma, Inc., rebranding to GlobeStar Therapeutics Corporation in July 2021.
Similar securities
Based on sector and market capitalization
Report issue